6533b7dcfe1ef96bd1272f62

RESEARCH PRODUCT

Pegylated liposomal doxorubicin (PLD) and weekly paclitaxel (P) as second line chemotherapy in metastatic bladder cancer.

Fabio FulfaroChiara IntriviciLorena IncorvaiaFortunato SorrentinoValeria AlbaneseCarmelinda LibriciTommaso PizzoGiuseppe CiceroAntonio RussoNicola GebbiaGiuseppe Badalamenti

subject

bladder cancer Pegylated liposomal doxorubicin (PLD)weekly paclitaxelhttp://hdl.handle.net/10447/43593